Kairos Pharma, LTD. (KAPA) stock
KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.44+0.04 (+10.08%)
Close on Nov 18, 2026Market cap $1.64MP/E –Yield –
Kairos Pharma total assets
Total assets on the balance sheet at the end of each period.
Kairos Pharma's total assets was $4.37M at Sep 30, 2026. For fiscal 2025 it was $6.54M, up 13.4% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.54M | +13.4% |
| FY2024 | Dec 31, 2024 | $5.77M | +497.7% |
| FY2023 | Dec 31, 2023 | $965.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.37M | -45.8% |
| Q2 FY2026 | Jun 30, 2026 | $4.46M | -33.2% |
| Q1 FY2026 | Mar 31, 2026 | $5.74M | -27.6% |
| Q4 FY2025 | Dec 31, 2025 | $6.54M | +13.4% |
| Q3 FY2025 | Sep 30, 2025 | $8.07M | +61.2% |
| Q2 FY2025 | Jun 30, 2025 | $6.67M | +591.5% |
| Q1 FY2025 | Mar 31, 2025 | $7.94M | – |
| Q4 FY2024 | Dec 31, 2024 | $5.77M | – |
| Q3 FY2024 | Sep 30, 2024 | $5.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $965.00K | – |
See a number that looks wrong?